The largest database of trusted experimental protocols

5 protocols using pr30012

1

Western Blot Analysis of Mitochondrial and Apoptosis Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total proteins were extracted using a lysis buffer, and equal amounts of protein lysates were separated on 12% or 10% SDS-PAGE and transferred to PVDF membranes (Millipore, Massachusetts, USA). After blocking and incubating with the indicated primary antibodies at 4 °C, the membranes were washed in TBST thrice for 5 min. Then, they were hybridized with anti-mouse (PR30012, Proteintech, Chicago, USA) or anti-rabbit (PR30011, Proteintech, Chicago, USA) IgG-linked horseradish peroxidase secondary antibodies for 1 h at room temperature. Finally, the membranes were visualized by enhanced chemiluminescence (Thermo Fisher Scientific, USA) and analyzed using the ImageJ software. The following antibodies and dilutions were used: anti-LRPPRC (dilution: 1:1000); anti-SLIRP (dilution: 1:1000); anti-FOXM1 (dilution: 1:1000); anti-PRDX3 (dilution: 1:1000); anti-MnSOD (dilution: 1:1000); anti-Catalase (dilution: 1:2000); anti-FLAG (dilution: 1:1000); anti-BCL2 (dilution: 1:1000); anti-BAX (dilution: 1:1000); anti-Cleaved CASP9 (dilution: 1:1000); anti-Cleaved CASP3 (dilution: 1:1000); anti-Cleaved PARP (dilution: 1:1000); CASP8 (dilution: 1:1000); and anti-α-Tubulin (dilution: 1:5000).
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of Lung Cancer Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin‐embedded lung cancer puncture specimens were sectioned into 4 µm sections for immunohistochemical staining. Haematoxylin and eosin staining was used for initial tissue sectioning. Subsequently, morphologically representative tumour areas were re‐sectioned. The sections were dewaxed with xylene and ethanol, followed by inhibition of endogenous peroxidase with a 3% hydrogen peroxide solution and incubation with 1% BSA at room temperature for 10 min. Incubation at 4°C overnight was carried out with primary antibodies: Anti‐SPP1 monoclonal antibody (1:100; LOT: #39o4953; affinity biosciences), Anti‐AGL (1:100; LOT: BB12027175; affinity biosciences), Anti‐CD44 (1:100; LOT: #37o8571; affinity biosciences), Anti‐cMET (1:100; LOT: #39o4953; affinity biosciences), Anti‐HGF (1:100; LOT: #44o6892; affinity biosciences).
Subsequently, secondary antibody treatment (Horseradish peroxidase anti‐mouse; PR30012, Proteintech) was conducted for 20 min at room temperature. Specific signals were visualised using diaminobenzidine substrate (DAB). Positive immunohistochemical manifestations, characterised by intracellular target proteins stained with brownish‐yellow granules, were counted in one randomly selected high magnification field of view, and the positive rate was calculated. On average, tens of fields of view were counted in each group (Supplementary Data 2).
+ Open protocol
+ Expand
3

Thymus Protein Extraction and Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected thymus for protein extraction using RIPA lysis buffer (Beyotime, Shanghai, China) supplemented with protease inhibitors (Beyotime, Shanghai, China). The protein from the thymus was separated by electrophoresis. Transfer the protein to the PVDF membrane at 4 °C. After blocking with 5% skimmed milk at room temperature for 2 h, the membranes were incubated with GPX4 primary antibody (ab40993, Abcam, Waltham, MA, USA) and GAPDH primary antibody (60004-1-Ig, Proteintech, Wuhan, China) at 4 °C overnight. After incubation with peroxidase-conjugated secondary antibodies (PR30011 and PR30012, Proteintech, Wuhan, China) for 1 h at room temperature. The signal was detected on an ImageQuant LAS 500 (GE, Chicago, IL, USA) using the ECL Kit (Biosharp, Hefei, China). GAPDH expression served as a loading control for quantification.
+ Open protocol
+ Expand
4

Western Blot Analysis of Atrial Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein was extracted from the atria tissue and cells by RIPA lysis buffer (Servicebio, g2002), and the protein concentration was determined by a BCA Protein Assay Kit (Aspen, as1086) according to the manufacturer's instruction. After mixing with loading buffer, protein samples were denatured in a boiling water bath for 10 minutes. Protein samples were separated on SDS-PAGE gels (10%), then transferred to PVDF membranes (0.45 μm, Millipore). QuickBlock (Epizym, ps108) was used to block for 10-20 minutes. Subsequently, the membranes were incubated with primary antibodies against GAPDH (Abcam, ab181602; 1 : 10000), Cav1.2 (Alomone, acc-003; 1 : 500), KCa3.1 (Bioss, bs-6675r; 1 : 500), CD63 (Biorbyt, orb11597; 1 : 1000), CD81 (Abcam, ab109201; 1 : 1000), TSG101 (Sigma, av38773; 1 : 500), FTH1 (Abcam, ab65080; 1 : 1000), GPX4 (Abcam, ab125066; 1 : 1000), and SLC7A11 (Biorbyt, orb325112; 1 : 500) overnight at 4°C. Then, the membranes were incubated with the secondary horseradish peroxidase-conjugated antibody (Proteintech, pr30012; 1 : 3000) at room temperature for 1 hour. GAPDH was used as a control to normalize the signal intensities. The AlphaEase FC software system was used to analyze the optical density value.
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of Breast Cancer Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
BC specimens that were formalin fixed and paraffin embedded were cut into 4‐μm sections for immunohistochemical staining. Hematoxylin and Eosin staining was used to section these tissues, which were then again sectioned after being indicated with morphologically representative specific tumour regions. Endogenous peroxidase was inhibited by 3% hydrogen peroxide solution after all sections were dewaxed with xylene and ethanol. 1% bovine serum albumin for 10 min at room temperature, followed by overnight incubation at 4°C with the following primary antibodies: monoclonal antibody against FCER2 (CD23; 1:400; 60208‐2‐Ig; Proteintech), anti‐CD21 (1:400; 24374‐1‐AP; Proteintech), anti‐CD20 (1:400; 60271‐1‐Ig; Proteintech), anti‐CD4 (1:400; 67786‐1‐Ig; Proteintech), anti‐CD8 (1:400; 66868‐1‐Ig; Proteintech) and anti‐BCL6 (1:400; 66340‐1‐Ig; Proteintech). The slides were then treated for 30 min at room temperature with secondary antibodies (horseradish peroxidase anti‐mouse, PR30012, Proteintech), and particular signals were exhibited with 3‐3′diaminobenzidine substrate (DAB), counterstained with hematoxylin, dried and sealed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!